Article
2’, 3’, 4’-Trihydroxychalcone Changes Estrogen Receptor Α Regulation of Genes and Breast Cancer Cell Proliferation by a Reprogramming Mechanism
2021-09-27
Abstract excerpt
<title>Abstract</title> <p>BackgroundMenopausal hormone therapy (MHT) is recommended for only five years to treat vasomotor symptoms and vulvovaginal atrophy because of safety issues with long-term treatment. We examined the ability of 2’, 3’, 4’-trihydroxychalcone (2’, 3’, 4’-THC) to modulate ERα-mediated responses on gene regulation and cell proliferation to identify drugs that can potentially overcome the adve...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5429412c-4aaa-579e-9fee-8abe71a82282
- DOI
- 10.21203/rs.3.rs-927121/v1
